Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.68 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.16.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DN.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.5.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DN.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.84 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.99NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
BA.2.3.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.1.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.10.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.79.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BY.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EA.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XJNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BR.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CL.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAUNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.25.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XADNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XABNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FT.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XALNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBWNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.251NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.256NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.77NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used